Cite
HARVARD Citation
Yusof, M. et al. (n.d.). SAT0556 Risk factors for severe infection and rationale for immunoglobulin monitoring during rituximab treatment in autoimmune rheumatic diseases. Annals of the rheumatic diseases. p. 987. [Online].